Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-09-09

FDA Approved: FAMOTIDINE — Supplemental Application (Sagent Pharmaceuticals)

View source ↗

Summary

FDA supplemental application submission for famotidine by Sagent Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Famotidine (famotidine)

Snippet

SUPPL AP for FAMOTIDINE (FAMOTIDINE)